NGL Fine-Chem (NGLFINE) | Stock Overview & Key Data
NGL Fine-Chem Performance Comparison
Stock Range
Today's Range
Low: ₹1,175.50
High: ₹1,245.00
on August 8, 2025
52 Week Range
Low: ₹957.00
High: ₹2,736.90
on February 19, 2025
on August 12, 2024
All-Time High: ₹2,823.90 on April 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR7.9B
EPS
33.29
P/E Ratio (TTM)
38.12
Forward P/E
N/A
P/B Ratio
2.78
PEG Ratio
N/A
Div. Yield
0.18%
ROE
7.48%
Beta
0.513
Debt to Equity
27.30
Financial Highlights
Profitability
Gross Margin
49.93%
Operating Margin
6.44%
Profit Margin
5.54%
Returns and Earnings
Return on Assets (TTM)
4.87%
Return on Equity (TTM)
7.48%
EBITDA
INR425.0M
Net Income (TTM)
INR211.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR617.82
Quarterly Revenue Growth (YoY)
14.80%
Quarterly Earnings Growth (YoY)
0.20%
Dividend Information
Last 12-Month Dividend
₹1.75
Current Dividend Yield
0.18%
3-Year Average Dividend Yield
0.08%
3-Year Average Annual Dividend
₹1.75
3-Year Total Dividends
₹5.25
Ex-Dividend Date
August 16, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| NGL Fine-Chem NGLFINE | 7.87B Small-cap | -8.26% | -3.03% | 11.40% | -20.20% | -33.16% | -52.15% | -22.76% | -35.55% |
| GlaxoSmithKline GLAXO | 453.58B Large-cap | -10.02% | -18.97% | -3.69% | 23.39% | 18.37% | -7.37% | 83.73% | 74.63% |
| Pfizer PFIZER | 232.88B Large-cap | -1.22% | -14.66% | 17.12% | 17.53% | -5.92% | -14.67% | 18.26% | 11.33% |
| Senores SENORES | 31.62B Small-cap | -1.95% | 10.42% | 34.86% | 18.36% | 14.20% | 13.83% | 13.83% | 13.83% |
| Sms Pharmaceuticals SMSPHARMA | 19.63B Small-cap | -2.01% | -6.63% | -7.22% | 6.32% | -12.61% | -20.98% | 157.68% | 136.24% |
| TTK Healthcare TTKHLTCARE | 16.62B Small-cap | -9.25% | -12.37% | -2.49% | -8.81% | -18.76% | -28.03% | 38.64% | 124.19% |
Ownership & Short Interest
Insider Ownership
73.79%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2K
Average 90-Day Volume
3K
NGL Fine-Chem Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in NGL Fine-Chem would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NGLFINE's 52-week high and low?
- In the last 52 weeks, NGL Fine-Chem reached a high of ₹2,736.90 (on August 12, 2024) and a low of ₹957.00 (on February 19, 2025).
- What is the market cap and P/E ratio for NGLFINE?
- Curious about NGL Fine-Chem's size and valuation? Its market capitalization stands at 7.87B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.12, and the forward P/E (looking ahead) is N/A.
- Does NGLFINE pay dividends? If so, what's the yield?
- Yes, NGL Fine-Chem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.18%, and the company has paid an average of ₹1.75 per share annually over the past 3 years.
- Who are NGL Fine-Chem's main competitors or similar companies to consider before investing?
When looking at NGL Fine-Chem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO453.58B Healthcare Drug Manufacturers - General -7.37% 83.73% Pfizer
PFIZER232.88B Healthcare Drug Manufacturers - General -14.67% 18.26% Senores
SENORES31.62B Healthcare Drug Manufacturers - General 13.83% 13.83% Sms Pharmaceuticals
SMSPHARMA19.63B Healthcare Drug Manufacturers - General -20.98% 157.68% TTK Healthcare
TTKHLTCARE16.62B Healthcare Drug Manufacturers - General -28.03% 38.64% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for NGL Fine-Chem Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of NGL Fine-Chem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.48%, the Debt to Equity ratio from the most recent quarter is 27.30, and its Gross Profit Margin stands at 49.93%.
- What is the recent revenue and earnings growth for NGLFINE?
- Looking at NGL Fine-Chem's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.80%, and quarterly earnings saw a YoY growth of 0.20%.
- How much of NGLFINE stock is held by insiders and institutions?
- Wondering who owns NGL Fine-Chem stock? Company insiders (like executives and directors) hold about 73.79% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.